Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this project is to study the efficacy of an anaplerotic treatment on brain energy profile evolution at an early stage of the Huntington disease.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Huntington Disease

Clinical Trial Details

NCT number	NCT01882062
Study type	Interventional
Source	Institut National de la Santé Et de la Recherche Médicale, France
Contact
Status	Completed
Phase	Phase 2
Start date	May 2013
Completion date	July 2013

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT03052712` - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies	N/A
	Not yet recruiting	`NCT04429230` - Non-invasive Brain Stimulation in Huntington's Disease	N/A
	Recruiting	`NCT05032196` - Study of WVE-003 in Patients With Huntington's Disease	Phase 1/Phase 2
	Recruiting	`NCT03599076` - Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease
	Terminated	`NCT04617860` - Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease	Phase 1/Phase 2
	Completed	`NCT05748288` - Development of the Virtual Unified Huntington's Disease Rating Scale
	Not yet recruiting	`NCT05360082` - Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
	Not yet recruiting	`NCT04370470` - Development of Assessments for Later Stage HD
	Recruiting	`NCT01834053` - Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.	Phase 1/Phase 2
	Completed	`NCT01458470` - A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease	Phase 2
	Completed	`NCT01357681` - Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)	Phase 2
	Completed	`NCT00980694` - Bioavailability of Ubiquinol in Huntington Disease	Phase 1
	Completed	`NCT00146211` - TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease	Phase 3
	Recruiting	`NCT01412125` - Study of Biomarkers That Predict the Evolution of Huntington's Disease	N/A
	Completed	`NCT00075140` - Family Health After Predictive Huntington Disease (HD) Testing	Phase 3
	Recruiting	`NCT04818060` - Preparing for Prevention of Huntington's Disease (PREVENT-HD)
	Active, not recruiting	`NCT04698551` - NIPD on cffDNA for Triplet Repeat Diseases
	Not yet recruiting	`NCT04301726` - Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD	Phase 1
	Completed	`NCT03421327` - Genetic Risk: Whether, When, and How to Tell Adolescents
	Recruiting	`NCT03296176` - Metabolomic Study in Huntington's Disease (METABO-HD)	N/A